SSII SS Innovations International, Inc.

$3.48 +6.10%

Healthcare · Surgical & Medical Instruments & Apparatus

SS Innovations International, Inc. (SSII) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $696 million. Shares last traded at $3.48, 69.8% below their 52-week high. Over the past year the stock is up 7.1%. Net profit margin is -28.5%, below the peer median of -7.6%. Revenue grew 105.7% year over year.

Market Cap

$696M

Shares Out

200.1M

EPS (TTM)

$-0.13

P/E Ratio

—

P/S Ratio

16.39

P/B Ratio

12.77

Dividend / Share

—

Dividend Yield

—

52-Week High

$11.52

52-Week Low

$3.05

Volume

430

Avg Vol (3m)

1,435.413

Performance

-0.85%

-13.00%

-30.61%

-31.09%

YTD

-38.52%

+7.08%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

41.37

SMA (50)

$4.08

SMA (200)

$5.45

Price vs SMA50

-14.73%

Price vs SMA200

-36.14%

ATR (14)

$0.21

Financials

Revenue

$42M

Net Income

$-12M

Gross Margin

46.0%

Operating Margin

-19.3%

Net Margin

-28.5%

Return on Equity

-22.2%

Return on Assets

-13.4%

Current Ratio

2.54

Debt / Equity

0.01

Revenue Growth (YoY)

+105.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.02	2026-05-13
FY 2025	$-0.06	2026-03-10
Q3 2025	$-0.05	2025-10-28
Q2 2025	$-0.03	2025-08-06
Q1 2026	$-0.03	2026-05-13
FY 2025	$-0.11	2026-03-10

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

SSII vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

16.39 / 2.52 med

+551% premium

Net margin vs peers

-28.5% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.